Neurogene (NGNE) EPS (Basic) (2013 - 2026)
Neurogene's (NGNE) quarterly EPS (Basic) came in at -$1.72 in Q1 2026, down 53.93% YoY from -$3.73 in Q1 2025, and down 45.95% on a QoQ basis from -$1.18 in Q4 2025.
Powered by 
Analysis
Neurogene (NGNE) EPS (Basic) (2013 - 2026) Analysis & Trends
Neurogene (NGNE) has 14 years of EPS (Basic) data on file, last reported at -$1.72 in Q1 2026.
- Quarterly EPS (Basic) fell 53.93% year-over-year to -$1.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.02 (up 8.02% YoY) and the FY2025 annual result came in at -$10.86, down 0.86% from the prior year.
- EPS (Basic) retreated to -$1.72 in Q1 2026, from -$1.18 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$1.1 in Q4 2024 to a low of -$28.4 in Q4 2023.
- A 5-year average of -$5.36 and a median of -$2.88 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) plunged 57.36% — and 2024, when it jumped 96.14%.
- Tracing NGNE's EPS (Basic) over 5 years: stood at -$18.05 in 2022, then sank by 57.36% to -$28.4 in 2023, then surged by 96.14% to -$1.1 in 2024, then fell by 7.36% to -$1.18 in 2025, then tumbled by 45.95% to -$1.72 in 2026.
- The last three EPS (Basic) figures came in at -$1.72 (Q1 2026), -$1.18 (Q4 2025), and -$1.13 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Neurogene | 864.53 Mn | 864.53 Mn | - | -1.54 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.54 |
| Mar 31, 2026 | -1.39 |
| Dec 31, 2025 | -1.17 |
| Sep 30, 2025 | -1.00 |
| Jun 30, 2025 | -1.10 |
| Mar 31, 2025 | -1.09 |
| Dec 31, 2024 | -1.12 |
| Sep 30, 2024 | -1.20 |
| Jun 30, 2024 | -1.10 |
| Mar 31, 2024 | -1.01 |
| Dec 31, 2023 | -28.40 |
| Sep 30, 2023 | -5.25 |
| Jun 30, 2023 | -4.22 |
| Mar 31, 2023 | -4.42 |
| Dec 31, 2022 | -4.23 |
| Sep 30, 2022 | -4.93 |
| Jun 30, 2022 | -5.75 |
| Mar 31, 2022 | -5.57 |
| Dec 31, 2021 | -5.51 |
| Sep 30, 2021 | -5.61 |